CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates the molecular mechanisms that drive tumor heterogeneity in breast cancer. By examining the interplay between signaling pathways and epigenetic programs, the research aims to identify ways to reduce tumor diversity and improve treatment outcomes for patients.
Breast cancer is diagnosed in ~1.4 million women worldwide and ~500,000 lives are lost to the disease annually.
Patients may do well after surgery and initial treatment, but drug resistant and fatal metastases often develop.
Improved treatment options are urgently needed.
The connecting thread of this project is the identification of epigenetic drivers of breast cell fate, tumor heterogeneity and metastasis.Tumor heterogeneity impinges on prognosis, response to therapy, and metastasis and is one…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Switzerland, Basel
Type: Public body
Activity type: Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
